The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.375
Bid: 1.30
Ask: 1.45
Change: 0.00 (0.00%)
Spread: 0.15 (11.538%)
Open: 1.375
High: 1.375
Low: 1.375
Prev. Close: 1.375
XSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Change

18 Mar 2022 07:00

RNS Number : 2093F
Xeros Technology Group plc
18 March 2022
 

18 March 2022

 

Xeros Technology Group plc

 

Board change

 

Xeros Technology Group plc (AIM: XSG, 'the Group', 'Xeros'), the licensor of proprietary solutions improving the sustainability and economics of garments and fabrics, announces today that Mark Nichols, CEO, has advised the Board that he wishes to leave Xeros to transition to a portfolio career at the end of 2022.

 

The Company is now at a point in time where it has successfully completed the development of its two platform technologies, secured broad IP protection and has entered into initial licensing agreements for both. In Mark's view, the Company would now benefit from new leadership to deliver on the next phase of its growth journey. Mark will remain with the business until 30 September 2022 to oversee the Group's ongoing commercialisation process and has committed to a comprehensive and orderly handover to his successor, for whom a search process is now underway.

As part of the above arrangements and in recognition of his contribution to the business over his six and half years of service, his status as a "good leaver" under the terms of the Company's EMI Share Option Scheme ("EMI Scheme") and Unapproved Share Option Scheme ("Unapproved Scheme") (together, the "Schemes") and to properly incentivise Mr Nichols during the transition period, the Remuneration Committee has determined:

 

1) to allow Mr Nichols to keep all outstanding options granted to him in 2020, 2021 and 2022 under the terms of the Schemes; and

2) to waive all unsatisfied performance criteria attaching to those options.

 

Discretion to do so is permitted under the terms of the Schemes.

 

The Remuneration Committee has further determined to allow the retained options to remain capable of exercise for a further three and a half years from his leaving date. This discretion is available to the Company's Remuneration Committee in respect of the EMI Scheme though is not so under the terms of the Unapproved Scheme. Accordingly, the Board (excluding Mr Nichols) is proposing to amend the terms of the option agreements granted to Mr Nichols under the Unapproved Scheme to allow such discretion to be taken. This amendment is deemed to be a related party transaction for the purposes of the AIM Rules. The Board (excluding Mr Nichols) having consulted with finnCap (as the Company's nominated adviser) consider that the terms of such proposed amendment are fair and reasonable insofar as the Company's shareholders are concerned.

 

Mr Nichols has agreed to cancel the options granted to him over a total of 18,901 ordinary shares of 15p each ("Ordinary Shares") in 2015, 2017 and 2018 which have an exercise price of £210 or £225 per share.

 

After allowing for the cancellation of the options granted in 2015, 2017 and 2018, Mr Nichols will hold options over a total of 415,246 Ordinary Shares (EMI Scheme: 246,200; Unapproved Share Option scheme: 169,046).

 

Klaas de Boer, Chairman of Xeros, said:

 

"After six and a half years of leading the development of Xeros we accept Mark's desire for a career change and fully appreciate his reasoning for it. The Company is now poised at the commercialisation stage of its development and Mark will leave the business very well positioned to grow significantly over the next 3+ years in partnership with global brands and manufacturers. They have the reach to deliver the benefits of our technologies to businesses and consumers across the globe. The Board has commenced the search for a new leader with the relevant skills and experience to complete a comprehensive commercialisation strategy for our exciting platform technologies."

 

This announcement contains inside information for the purposes of Market Abuse Regulation (Regulation (EU) No. 596/2014) as retained and applicable in the UK pursuant to S3 of the European Union (Withdrawal) Act 2018 ('MAR').

 

 

Enquiries:

Xeros Technology Group plc

Klaas de Boer, Chairman

Paul Denney, Chief Financial Officer

Tel: 0114 321 6328

 

finnCap Limited (Nominated Adviser and Broker)

Julian Blunt/Teddy Whiley, Corporate Finance

Andrew Burdis/Sunila de Silva, ECM

Tel: 020 7220 0570

Notes to Editors

 

With close to 40 patent families, Xeros' revolutionary platform technologies, XTend™ and XFiltra™ set new standards for performance and sustainability across our clothing's lifecycle. By reducing the consumption of valuable natural resources and preventing microfibre and microplastic pollution, Xeros greatly reduces the impact of our clothes on the planet.

Backed by science, we set new standards for significantly reduced water consumption, lower carbon and effluent emissions, and improved garment care/life at the manufacturing stage and throughout laundry processes, in industry, and in the home. Xeros' technologies deliver a unique combination of unbeatable sustainability outcomes, improving performance whilst reducing costs. 

The manufacture of clothes and their subsequent care consumes vast amounts of our finite, valuable resources. Xeros licenses new technologies to enable us all to consume less, helping to protect the world for our future. 

For more information, please visit - http://www.xerostech.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAJRMMTMTIBTRT
Date   Source Headline
3rd May 20247:00 amRNSAppointment of Board Observer
1st May 20242:14 pmRNSTotal Voting Rights
30th Apr 20241:45 pmRNSTR-1
29th Apr 20245:20 pmRNSTR-1
29th Apr 20243:40 pmRNSTR-1
29th Apr 20243:14 pmRNSTR-1
29th Apr 20242:18 pmRNSTR-1
29th Apr 20242:14 pmRNSTR-1
26th Apr 20245:01 pmRNSTR-1
26th Apr 202412:09 pmRNSTR-1
25th Apr 20242:09 pmRNSResult of GM, Director Dealings and TVR
19th Apr 20241:13 pmRNSResult of Retail Offer
9th Apr 20242:58 pmRNSTR-1
8th Apr 20244:30 pmRNSPosting of Circular and Notice of General Meeting
8th Apr 20243:56 pmRNSTR-1
5th Apr 202410:22 amRNSTotal Voting Rights
4th Apr 20246:29 pmRNSResult of Fundraising
4th Apr 20244:49 pmRNSRetail Offer
4th Apr 20244:40 pmRNSFundraising to raise up to £5.5 million
11th Mar 20247:00 amRNSAlex Tristram joins the Board as Finance Director
8th Feb 20245:03 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSHolding(s) in Company
8th Feb 20242:51 pmRNSHolding(s) in Company
8th Feb 20249:07 amRNSHolding(s) in Company
7th Feb 20242:05 pmRNSHolding(s) in Company
6th Feb 20243:24 pmRNSHolding(s) in Company
6th Feb 202410:22 amRNSHolding(s) in Company
5th Feb 20247:00 amRNSTR-1
2nd Feb 20247:00 amRNSExercise of Warrants, Issue of Equity and TVR
29th Jan 202412:00 pmRNSHolding(s) in Company
26th Jan 20241:35 pmRNSExercise of Warrants and Total Voting Rights
19th Jan 20243:31 pmRNSExercise of warrants and Total Voting Rights
18th Jan 20242:37 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSDirector/PDMR Shareholding
17th Jan 20242:22 pmRNSHolding(s) in Company
16th Jan 20244:38 pmRNSHolding(s) in Company
15th Jan 20245:32 pmRNSHolding(s) in Company
9th Jan 20242:33 pmRNSHolding(s) in Company
8th Jan 20246:00 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSHolding(s) in Company
2nd Jan 20241:56 pmRNSBlock listing Interim Review
21st Dec 20231:38 pmRNSResults of Warrant Holder Meeting
15th Dec 202311:55 amRNSHolding(s) in Company
4th Dec 20237:00 amRNSCircular Posting & Warrant Holder Meeting Notice
29th Nov 20237:00 amRNSTerms of Warrants Consultation and Trading Update
20th Nov 20233:45 pmRNSHolding(s) in Company
14th Nov 20235:01 pmRNSHolding(s) in Company
8th Nov 20233:29 pmRNSHolding(s) in Company
3rd Nov 20233:11 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNS2023 Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.